|
Section 5. Scope, Duration, and Significance of Use.
The legislative history of the Controlled Substances Act
indicates that scheduling decisions must include consideration
of the costs of law enforcement attendant to a drug or substance's
scheduling, as well as a consideration of the impact of such
law enforcement on the young.
The absolute yet unenforceable schedule I prohibition contributes
to an unfavorable set and setting accompanying school-age
access and exposure to marijuana. Not only are students provided
access to marijuana, they are also grossly uninformed and
misled about the substance and its use.
Adherence to the polarized and unscientific 'use = abuse'
model obstructs the development of effective, research based
policy and drug-abuse prevention programs; this restrains
progress in protecting school-age youths from the dangers
presented by all drugs, legal or not.
Marijuana prohibition makes criminals out of patients who
use marijuana for legitimate therapeutic purposes, and forces
patients to choose between honoring the law and honoring their
own health.
The absolute yet unenforceable schedule I prohibition creates
tremendous ethical problems for physicians and health-care-providers,
professionals well-aware of the widening gap between existing
governmental policies and the developing support for marijuana's
therapeutic potential in scientific and medical literature,
and professionals who are seemingly instructed by law to discourage
their patients from using marijuana even if such use has obvious
therapeutic benefits.
The failure of the Department of Health and Human Services,
and of the National Institute on Drug Abuse specifically,
to address this widening breach between recent research about
marijuana and the findings required to sustain marijuana's
schedule I status unfairly and inappropriately makes our federal
law enforcement officials, particularly officials of the Drug
Enforcement Administration, appear to be heartless, insensitive,
self-serving idiots.
The federal failure to reconcile marijuana's schedule I status
with contemporary medical and scientific evidence places an
unfair and expensive burden on state criminal justice agencies
and their limited budgets.
Marijuana's schedule I status and the high priority it places
on domestic and international marijuana eradication has the
unintended effect of transforming domestic law enforcement
activity into a massive market and price support mechanism
for entrepreneurs here and abroad.
Marijuana's schedule I status mandates high priority for
domestic marijuana eradication efforts; the nearly impossible
task presented to law enforcement results in extreme measures
and increasing federalization of local and state judicial
authority.
One of the results of the DEA's domestic marijuana eradication
program is that in the mid 1990's domestic marijuana cultivation
is now so extensive and decentralized that the DEA admits
they can no longer estimate how much marijuana is grown in
the United States. If they have lost hope of even estimating
how much is grown, they have abandoned hope of ever eliminating
marijuana cultivation in the United States, and of ever enforcing
marijuana's schedule I status as a completely prohibited substance.
The purpose of schedule I is to regulate the manufacture of
drugs and substances with the highest potential for abuse;
without control of domestic marijuana cultivation such regulation
is impossible.
References Cited in Section 5.
Abood, M.E., and Martin, B.R., , "Neurobiology of Marijuana
Abuse," Trends in Pharmacological Sciences 13:201-206, 1992.
Aldrich, M., Mikuriya, T., et al., Fiscal Savings In California
Marijuana Law Enforcement, 1976 - 1985 Attributable to the
Moscone Act of 1976, (Berkeley, CA: Medi-Comp Press,) 1986.
Aldrich, M.R., Mikuriya, T., "Savings in California, Marijuana
Law Enforcement Costs Attributable to the Moscone Act of 1976--A
Summary." Journal of Psychoactive Drugs. Vol. 20(1):75-81,
1988.
Alliance for Cannabis Therapeutics v. Drug Enforcement Administration.
15 F3d 1131 (1994, App DC)
Brady, J.V., "What's a Radical Behaviorist Like You Doing
in a Nice Pharmacology Club like CPDD?" In: Problems of Drug
Dependence, 1992. Proceedings of the 54th Annual Scientific
Meeting, The Committee on Problems of Drug Dependence, Inc.
Harris, L. (ed), National Institute on Drug Abuse Research
Monograph 132. (Washington, D.C.: U.S. Govt. Print. Off.,)
1993. pg 19 -28.
Brownell, G., "Marijuana and the Law in California: A Historical
and Political Overview." Journal of Psychoactive Drugs. Vol.
20(1):71-74, 1988.
Chalsma, A., Boyum, D., Marijuana Situation Assessment. (Washington,
D.C.: Office of National Drug Control Policy,) 1994.
Consroe, P., Laguna, J. et al., "Controlled Clinical Trial
of Cannabidiol in Huntington's Disease." Pharmacology, Biochemistry,
& Behavior. 40:701-708, 1991.
Gettman, J., Cannabis Suppression and Marijuana Crop Value.
(Washington, D.C.: National Organization for the Reform of
Marijuana Laws,) 1993.
Grinspoon, L. Marihuana, The Forbidden Medicine. (New Haven:
Yale University Press,) 1993.
Herkenham, M., "Cannabinoid Receptor Localization in Brain:
Relationship to Motor and Reward Systems," In P.W. Kalivas
and H.H. Samson (eds.), The Neurobiology of Drug and Alcohol
Addiction. Annals of the American Academy of Sciences. 654:19-32,
1992.
Herkenham, M., Lynn, A.B., et al., "Cannabinoid Receptor
Localization in Brain," Proceedings of the National Academy
of Sciences, 87:1932-1936, 1990.
Hollister, L.E. "Health Aspects of Cannabis", Pharmacological
Reviews, 38(1):1-20. 1986.
Mechoulam, R., , "Interview with Professor Raphael Mechoulam,
Codiscoverer of THC", The International Journal of the Addictions,
21(4&5), 579-587, 1986. (The interview was conducted by
Stanley Einstein in Jerusalem on January 14, 1985.)
National Drug Enforcement Policy Board, "Analysis of the
Domestic Cannabis Problem and The Federal Response, Staff
Report" (Washington, D.C.: NDEPB,) 1986.
National Drug Enforcement Policy Board, "National and International
Drug Law Enforcement Strategy" (Washington, D.C.: NDEPB,)
1987.
National Drug Enforcement Policy Board, "Federal Drug Enforcement
Progress Report, 1984-1985" (Washington, D.C.: NDEPB,) 1986.
National Narcotics Intelligence Consumers Committee, "1989
Narcotics Intelligence Estimate" (Washington, D.C.:DEA,) 1990.
National Narcotics Intelligence Consumers Committee, "1990
Narcotics Intelligence Estimate" (Washington, D.C.:DEA,) 1991.
National Narcotics Intelligence Consumers Committee, "1991
Narcotics Intelligence Estimate" (Washington, D.C.:DEA,) 1992.
Rhodes, W., Scheiman, P., et al., What America's Users Spend
on Illegal Drugs, 1988-1993. (Washington, D.C.: Office of
National Drug Control Policy,) 1995. Prepared by Abt Associates
under contract no. DC2C04.
Shafer, R., Commission on Marihuana and Drug Abuse, (1972)
Marihuana, a signal of misunderstanding; first report of the
National Commission on Marihuana and Drug Abuse, March 1972.
(Washington, D.C.: U.S. Govt. Print. Off.,) 1972.
Shafer, R., Commission on Marihuana and Drug Abuse, (1973)
Drug Use In America: Problem In Perspective, second report
of the National Commission on Marihuana and Drug Abuse, Vol.
I. March 1973. (Washington, D.C.: U.S. Govt. Print. Off.,)
1973.
Swann, N., "Marijuana's Natural Counterpart Discovered."
NIDA Notes. September/October 1993. pg. 8.
U.S. Code Congressional and Administrative News. 91st Congress
-- Second Session, 1970. Vol. 3. Legislative History. Comprehensive
Drug Abuse Prevention and Control Act of 1970 [P.L. 91-513].
pg. 4566 - 4657.
U.S. Congress, Office of Technology Assessment (1994) Technologies
for Understanding and Preventing Substance Abuse and Addiction,
OTA-EHR-597 (Washington, DC: U.S. Government Printing Office,)
September 1994.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1982 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1983.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1983 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1984.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1984 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1985.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1985 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1986.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1986 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1987.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1987 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1988.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1988 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1989.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1989 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1990.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1990 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1991.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1991 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) December 1991.
U.S. Department of Justice, Drug Enforcement Administration,
Cannabis Investigation Section. 1992 Domestic Cannabis Eradication/Suppression
Program. (Washington, D.C.:DEA,) 1993.
U.S. Department of Justice, Drug Enforcement Administration,
Docket No. 86-22. Marijuana Scheduling Petition, Denial of
Petition. 54 Fed. Reg. 53,787 (1989)
U.S. Department of Justice, Drug Enforcement Administration,
Docket No. 86-22. Marijuana Scheduling Petition, Denial of
Petition; Remand. 57 Fed. Reg. 10,499 (1992)
Zinberg, N. Drug, Set, and Setting. (New Haven: Yale University
Press,) 1984.
|